Trump’s 2025 tariff policy initially exempted certain goods, like pharmaceuticals and semiconductors, from the 10% baseline and reciprocal tariffs. The administration aims to protect U.S. industries, but debates persist over whether exemptions undermine the strategy or prevent shortages and price spikes worldwide.
Response rates from 53.2k America voters.
79% Yes |
21% No |
69% Yes |
18% No |
6% Yes, and extend exemptions to all critical supply chain items |
1% No, exemptions weaken the goal of reshoring manufacturing |
5% Yes, but review exemptions annually to encourage domestic production |
1% No, all imports should face tariffs to ensure fair competition |
Trend of support over time for each answer from 53.2k America voters.
Loading data...
Loading chart...
Trend of how important this issue is for 53.2k America voters.
Loading data...
Loading chart...
Unique answers from America voters whose views went beyond the provided options.
@B4SBJL72mos2MO
There should not be a tariff war going on in the first place, but if there are tariff's essentials should be exempt.
@wiselaura2mos2MO
Yes, and extend exemptions to all critical supply chain items but review exemptions annually to encourage domestic production.
@8BP8QFF 2mos2MO
This question assumes that we should have tariffs at all. This is an unnecessary tax on the American Consumer when prices are already at record highs.
@B5YHTLG1 day1D
As the POTUS said himself, all the companies have to do is move into the United States to avoid the high tariffs. But recently the President has back tracked his actions and die down on the high tariffs.
@B5YDBFP 2 days2D
No, but let consumers in very low income brackets pay less money for the essential goods (if there is an increase in consumer prices on the essential goods).
@ProudJew 4 days4D
"Security Bridge Strategic Exemptions"
"Yes, but with a comprehensive strategy that prioritizes American lives while building domestic capacity. Essential pharmaceuticals and critical medical supplies get temporary exemptions with mandatory domestic production requirements - companies must invest tariff savings into U.S. manufacturing within 3 years or face retroactive penalties. Use exemption revenue to fund domestic pharmaceutical research and production facilities. For other critical supply chain items, create a tiered system: immediate exemptions for items where shortages could cause deaths or national security risks, with decreasing exemptions as domestic alternatives become viable. The goal isn't permanent dependency - it's ensuring Americans don't die while we rebuild our manufacturing base."
@B5X56XM1wk1W
Maybe. I do not feel that I know enough about the topic to fully form an opinion. However, I feel that essential resources should be supported. Though, I could see it getting taken advantage of. I also just do not feel much or any support for the pharmaceutical industry.
@B5PK4B74wks4W
Yes, but outline what should be considered essential so that companies don't label their products as "essential" to avoid paying tariffs.
Join in on the most popular conversations.